Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Company Appoints New SVP, Marketing for PBM Business

Wed. November 04, 2009; Posted: 09:07 AM
Stocks RSS
WOONSOCKET, R.I., Nov 04, 2009 /PRNewswire via COMTEX/ -- CVS | Quote | Chart | News | PowerRating -- CVS Caremark (NYSE: CVS | Quote | Chart | News | PowerRating) today announced the appointment of Len Greer to the position of SVP, Marketing for its pharmacy benefit management business. Greer assumes responsibility for the company's PBM marketing from Jack Bruner, who is transitioning to the new role of EVP, Strategic Development.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )

Greer brings twenty years of experience in marketing, strategy and product development to CVS Caremark. He joins the company from ActiveHealth where he was the EVP, Marketing responsible for developing and implementing marketing strategies to drive brand awareness in the health plan and plan sponsor marketplace. Prior to his tenure with ActiveHealth he spent six years at Medco Health in various senior marketing roles. Before joining Medco, Greer was a management consultant at McKinsey & Company, where he assisted clients on issues of marketing, strategy, product development and operations.

"Len's analytical background, knowledge of the industry and strong marketing skills make him uniquely qualified to help deliver our messages effectively in the marketplace," commented Tom Ryan, President, Chairman and CEO.

Len holds a bachelor's degree from the Illinois Institute of Technology and a master's degree in business administration from the University of Michigan.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 7,000 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at www.cvscaremark.com/investors, as well as through the press room section of the Company's Web site, at www.cvscaremark.com/newsroom.

    Media Contact:
    Eileen Howard Dunn                  Nancy Christal
    CVS Caremark                        CVS Caremark
    Senior Vice President               Senior Vice President
    Corporate Communications            Investor Relations
    (401) 770-4561                      (914) 722-4704

SOURCE CVS Caremark

http://info.cvscaremark.com
For full details on Cvs Caremark Corp (CVS) click here. Cvs Caremark Corp (CVS) has Short Term PowerRatings of 5. Details on Cvs Caremark Corp (CVS) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [CVS]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.